Brain implants, once confined to the realm of science fiction, are steadily emerging as potential game-changers in humanity’s future, as evidenced by a series of medical trials.
Considerable investment is flowing into specialized companies focused on finding treatments for severe medical conditions. Pioneering research has already yielded promising outcomes.
In May, a Dutch individual paralyzed in a motorcycle accident regained walking ability through implants that restored communication between his brain and spinal cord. This achievement is one of several striking trials generating substantial excitement in the field.
Between 2010 and 2020, more than $30 billion was invested in neurotechnology, according to UNESCO. The momentum continues, driven partly by advances in artificial intelligence (AI), which researchers use to interpret implant data.
Elon Musk, a prominent figure in the tech industry, has refocused efforts on his Neuralink venture after receiving permission to test human implants, resulting in a funding injection of $280 million.
Other companies, helmed by less high-profile leaders, are also flourishing, offering hope to those afflicted by conditions such as rare nerve disorders and severe epilepsy.
One such company, Synchron, secured $75 million in funding this year, with backing from luminaries like Bill Gates and Jeff Bezos. Synchron’s implant, designed for patients with Amyotrophic Lateral Sclerosis (ALS), allows communication through eye movements and thoughts, without requiring invasive surgery.
Dr. David Putrino, who directed a medical trial at Mount Sinai Hospital, highlighted the success of the Synchron implant in terms of safety and long-term brain monitoring.
Tom Oxley, the founder of Synchron, views brain-computer interface (BCI) technology as reaching a pivotal juncture, stressing the need for widespread accessibility.
Nevertheless, considerable challenges remain before such accessibility can be achieved, especially since the most impactful outcomes often arise from invasive implants.
For instance, a patient named Ian Burkhart, paralyzed after a diving accident, described the moment he regained control of his arms through an implant as “magical.” However, these Utah array implants aren’t comfortable and can face immune system attacks within the brain.
As cells cover the implants, their ability to transmit brain signals diminishes. Despite this, some researchers are exploring non-implant techniques, such as brain scan-based AI models to understand thoughts.
While most neurotechnology players focus on medical applications, Elon Musk’s ambitions extend beyond. He envisions the potential for telepathy and memory storage using implants, even suggesting the idea of transferring memories into new bodies or robotic forms.
Though these ideas remain distant from realization, Musk believes implants could enhance humans and bridge the gap between our species and superintelligent machines.
